PO.TB05.01 · 肿瘤生物学

在人诱导多能干细胞模型中阐明PAX3::FOXO1肿瘤起始机制

Elucidation of PAX3::FOXO1 tumor initiation mechanisms in human induced pluripotent stem cell models

海报缩略图:在人诱导多能干细胞模型中阐明PAX3::FOXO1肿瘤起始机制
编号 630 展板 9 时间 4/19 02:00–05:00 区域 Section 26 主讲 Bradley Stevens, BS;MS
分会场 Developmental Origins, Drivers, and Heterogeneity in Pediatric Cancer
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Bradley T. Stevens, Yang Zhang, Brian J. Abraham, Mark E. Hatley

St. Jude Children's Research Hospital, Memphis, TN

摘要 Abstract

中文摘要
横纹肌肉瘤(RMS)是最常见的儿童软组织肉瘤。腺泡型RMS(ARMS)由t(2;13)(q35;q14)或t(1;13)(p36;q14)驱动,分别产生PAX3-FOXO1(P3F)和PAX7-FOXO1(P7F)融合癌蛋白,预后较差。为发现新靶点,需要更深入地理解P3F介导的肿瘤发生机制。现有模型系统在时间、部位以及其他肿瘤类型的形成方面无法再现人类疾病。此前,我们实验室建立了一种源自人诱导多能干细胞(iPSCs)的ARMS模型系统,在内皮定向分化过程中强制表达P3F可阻断内皮成熟,转而将细胞重编程为在小鼠中形成ARMS肿瘤的骨骼肌样细胞。在此模型基础上,我们构建了由可降解P3F-FKBP12 F36V驱动的多西环素诱导型iARMS模型(ddP3F细胞),从而能够精细控制P3F的表达。P3F的降解并未显著降低细胞活力或增殖,但降低了ddP3F细胞进行肌源性分化的能力。P3F阴性的ddP3F细胞在多次传代中持续增殖,并保留形成集落的能力。转录分析显示P3F丢失后ARMS细胞状态保持稳定。综上所述,这些数据表明P3F对ARMS命运起始很重要,但对维持并不重要,提示需要进一步研究起始事件以深入了解ARMS生物学。为阐明P3F介导的起始机制,我转向此前建立的iARMS模型。我利用CUT&RUN对P3F和H3K27ac进行分析,以评估P3F的占据情况和增强子景观,并利用RNA-seq评估转化事件全程各时间点的基因表达变化。分析发现ARMS命运确定发生在P3F表达后两天内,并在整个时间进程中得到强化。在机制上,P3F建立了新的增强子景观,导致一个肌源性转录因子和少数几个神经转录因子(核心TFs)的早期表达。单细胞多组学分析证实了早期命运确定,并揭示核心TFs的异质性表达。综上所述,这些数据表明P3F最初通过改变增强子景观,借助肌源性和神经转录因子来确立细胞命运,但这两类因子不一定在同一细胞中。总体而言,我们的新型细胞模型揭示了ARMS细胞命运维持不依赖P3F的机制,揭示了P3F介导ARMS细胞状态确立的机制,并提供了一个剖析ARMS细胞状态所需特定依赖性的平台。理解ARMS肿瘤发生的基本机制,可更清晰地认识关键疾病决定因素,从而构建更好的模型系统、聚焦临床前工作并识别新靶点。
查看英文原文 English abstract
Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma. Alveolar RMS (ARMS) is driven by either t(2;13)(q35;q14) or t(1;13)(p36;q14) resulting in the PAX3-FOXO1 (P3F) and PAX7-FOXO1 (P7F) fusion oncoproteins, respectively and has a poor prognosis. A deeper understanding of P3F mediated tumorigenesis is needed to discover novel targets. Current model systems fail to recapitulate the human disease in terms of timing, location, and the formation of other tumor types. Previously, our lab generated an ARMS model system derived from human induced pluripotent stem cells (iPSCs), in which forced P3F expression during endothelial directed differentiation blocked endothelial maturation instead reprogramming cells to skeletal muscle-like that form ARMS tumors in mice. Building off this model, we generated a doxycycline inducible iARMS model driven by degradable P3F-FKBP12 F36V (ddP3F cells) allowing for fine control over P3F expression. Degradation of P3F did not significantly reduce viability or proliferation but reduced the ability of ddP3F cells to undergo myogenic differentiation. P3F-negative ddP3F cells continued to proliferate for multiple passages and retained the ability to form foci. Transcriptional analyses revealed ARMS cell states remained stable upon P3F loss. Taken together, this data shows that P3F is important for ARMS fate initiation but not maintenance, indicating further examination of the initiation event was needed for insight into ARMS biology. To elucidate the P3F-mediated initiation mechanism, I turned to our previously established iARMS model. I utilized CUT&RUN for P3F and H3K27ac to assess P3F occupancy and enhancer landscape and RNA-seq to assess gene expression changes at timepoints throughout the transformation event. Analysis of this data revealed that ARMS fate commitment occurred within two days of P3F expression that was reinforced throughout the time course. Mechanistically, P3F established a novel enhancer landscape resulting in the early expression of one myogenic and a few neural transcription factors (core TFs). Single cell multiome profiling confirmed early fate commitment and revealed heterogeneous expression of the core TFs. Taken together, these data show that P3F initially establishes cell fate through enhancer landscape alterations with both myogenic and neural transcription factors but not necessarily in the same cells. Overall, our novel cellular models revealed insights into P3F independent maintenance of ARMS cell fate, uncovered a mechanism of P3F-mediated establishment of ARMS cell state, and provides a platform to dissect the specific dependencies required for ARMS cell state. Understanding the fundamental mechanism of ARMS tumorigenesis provides greater resolution into the key disease determinants to generate better model systems, focus pre-clinical efforts, and identify novel targets.
利益披露 Disclosure
B. T. Stevens, None.. Y. Zhang, None.. B. J. Abraham, None.. M. E. Hatley, None.

← 返回 AACR 2026 检索